Cost and cost effectiveness are different

Publisher Website
Google Scholar
Abstract
EDITOR,—Jeannette Naish and colleagues seem surprised at the relatively low levels of generic prescribing of drugs in asthma, especially steroids.1 They should not be. Recent correspondence in the BMJ testifies to the controversy fuelled by commercial …